<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101170508</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30450</journal-id>
<journal-id journal-id-type="nlm-ta">J Thromb Haemost</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Thromb. Haemost.</journal-id>
<journal-title-group>
<journal-title>Journal of thrombosis and haemostasis : JTH</journal-title>
</journal-title-group>
<issn pub-type="ppub">1538-7933</issn>
<issn pub-type="epub">1538-7836</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27079292</article-id>
<article-id pub-id-type="pmc">5322813</article-id>
<article-id pub-id-type="doi">10.1111/jth.13338</article-id>
<article-id pub-id-type="manuscript">NIHMS849199</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Szabo</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="A1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Samson</surname>
<given-names>A. L.</given-names>
</name>
<xref ref-type="aff" rid="A2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lawrence</surname>
<given-names>D. A.</given-names>
</name>
<xref ref-type="aff" rid="A3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Medcalf</surname>
<given-names>R. L.</given-names>
</name>
<xref ref-type="aff" rid="A2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bugge</surname>
<given-names>T. H.</given-names>
</name>
<xref ref-type="aff" rid="A1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>*</label>Proteases and Tissue Remodeling Section Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA</aff>
<aff id="A2"><label>†</label>Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria Australia</aff>
<aff id="A3"><label>‡</label>Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, MI, USA</aff>
<author-notes>
<corresp id="CR1">Address correspondence and reprint requests to: Thomas H. Bugge, Ph.D., Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Room 320, Bethesda, MD 20892, Phone: (301) 435-1840, Fax: (301) 402-0823, <email>thomas.bugge@nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>14</volume>
<issue>8</issue>
<fpage>1618</fpage>
<lpage>1628</lpage>
<!--elocation-id from pubmed: 10.1111/jth.13338-->
<abstract>
<title>Summary</title>
<sec id="S1">
<title>Background</title>
<p id="P1">The ability to generate defined null mutations in mice revolutionized the analysis of gene function in mammals. However, gene-deficient mice generated by using 129-derived embryonic stem cells may carry large segments of 129 DNA, even when extensively backcrossed to reference strains, such as C57BL/6J, and this may confound interpretation of experiments performed in these mice. Tissue plasminogen activator (tPA), encoded by the <italic>PLAT</italic> gene, is a fibrinolytic serine protease that is widely expressed in the brain. A number of neurological abnormalities have been reported in tPA-deficient mice.</p>
</sec>
<sec id="S2">
<title>Objectives</title>
<p id="P2">To study genetic contamination of tPA-deficient mice.</p>
</sec>
<sec id="S3">
<title>Materials and methods</title>
<p id="P3">Whole genome expression array analysis, RNAseq expression profiling, low- and high-density SNP analysis, bioinformatics, and genome editing was used to analyze gene expression in tPA-deficient mouse brains.</p>
</sec>
<sec id="S4">
<title>Results and conclusions</title>
<p id="P4">Genes differentially expressed in the brain of <italic>Plat</italic><sup>−/−</sup> mice from two independent colonies highly backcrossed onto the C57BL/6J strain clustered near <italic>Plat</italic> on chromosome 8. SNP analysis attributed this anomaly to about 20 Mbp of DNA flanking <italic>Plat</italic> being of 129 origin in both strains. Bioinformatic analysis of these 129-derived chromosomal segments identified a significant number of mutations in genes co-segregating with the targeted <italic>Plat</italic> allele, including several potential null mutations. Using zinc finger nuclease technology, we generated novel “passenger mutation”-free isogenic C57BL/6J-<italic>Plat</italic><sup>−/−</sup> and FVB/NJ-<italic>Plat</italic><sup>−/−</sup> mouse strains by introducing an 11 bp deletion in the exon encoding the signal peptide. These novel mouse strains will be a useful community resource for further exploration of tPA function in physiological and pathological processes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>brain</kwd>
<kwd>congenic mice</kwd>
<kwd>gene targeting</kwd>
<kwd>mutation</kwd>
<kwd>tissue plasminogen activator</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>